CytomX Therapeutics Other Operating Expenses (Quarterly) Analysis

CytomX Therapeutics, Inc. (CTMX)

5.80 +0.36 (+6.62%) USD | NASDAQ | Feb 25, 16:00

5.80 0.00 (0.00%) After-Hours: 16:03

View Other Operating Expenses (Quarterly) for CTMX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Operating Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Operating Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Operating Expenses (Quarterly) Benchmarks

Start Trial

REGENXBIO, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Savara, Inc.	--
BioMarin Pharmaceutical, Inc.	--